topotecan (Sagent Pharmaceuticals)
Welcome to the PulseAid listing for the topotecan drug offered from Sagent Pharmaceuticals. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sagent Pharmaceuticals |
NON-PROPRIETARY NAME: | topotecan |
SUBSTANCE NAME: | TOPOTECAN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2014-12-15 |
END MARKETING DATE: | 0000-00-00 |
topotecan HUMAN PRESCRIPTION DRUG Details:
Item Description | topotecan from Sagent Pharmaceuticals |
LABELER NAME: | Sagent Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/mL) |
START MARKETING DATE: | 2014-12-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 25021-236_0d9ddc95-c952-4822-9bbe-51edc6023f6b |
PRODUCT NDC: | 25021-236 |
APPLICATION NUMBER: | NDA022453 |
Other TOPOTECAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: